• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.

作者信息

Shaikh Aisha, Zeldis Etti, Campbell Kirk N, Chan Lili

机构信息

Division of Nephrology, James J. Peters Veterans Affairs Medical Center, Bronx, New York.

Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.

出版信息

Clin J Am Soc Nephrol. 2021 Feb 8;16(2):290-292. doi: 10.2215/CJN.11120720. Epub 2020 Oct 14.

DOI:10.2215/CJN.11120720
PMID:33055191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7863659/
Abstract
摘要

相似文献

1
Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis.血液透析患者中SARS-CoV-2病毒RNA的长期脱落及对SARS-CoV-2的IgG抗体反应
Clin J Am Soc Nephrol. 2021 Feb 8;16(2):290-292. doi: 10.2215/CJN.11120720. Epub 2020 Oct 14.
2
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.住院 COVID-19 患者的传染性 SARS-CoV-2 脱落与血清抗体反应的关系。
BMC Infect Dis. 2021 May 27;21(1):494. doi: 10.1186/s12879-021-06202-8.
3
IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan.日本重症和轻症 COVID-19 患者的 IgG 抗体、SARS-CoV-2 载量和预后指标。
J Nippon Med Sch. 2021 Sep 1;88(4):380-383. doi: 10.1272/jnms.JNMS.2021_88-417. Epub 2020 Nov 30.
4
Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.新型冠状病毒（SARS-CoV-2）RNA长期脱落：并非罕见现象。
J Med Virol. 2020 Nov;92(11):2286-2287. doi: 10.1002/jmv.25952. Epub 2020 May 22.
5
Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.新冠病毒感染后6个月内肾移植受者体内抗新冠病毒抗体的下降与丧失
Kidney Int. 2021 Feb;99(2):486-488. doi: 10.1016/j.kint.2020.12.001.
6
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
7
Unified platform for genetic and serological detection of COVID-19 with single-molecule technology.基于单分子技术的新冠病毒基因和血清学联合检测通用平台。
PLoS One. 2021 Jul 26;16(7):e0255096. doi: 10.1371/journal.pone.0255096. eCollection 2021.
8
Viral Clearance and Serological Response to SARS-CoV-2 in Kidney Transplant Recipients.肾移植受者对 SARS-CoV-2 的病毒清除和血清学反应。
Transplant Proc. 2021 May;53(4):1180-1186. doi: 10.1016/j.transproceed.2020.11.008. Epub 2020 Dec 17.
9
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.30 种用于识别 COVID-19 免疫反应的侧向流动免疫分析的操作特性。
J Immunol Methods. 2021 Sep;496:113096. doi: 10.1016/j.jim.2021.113096. Epub 2021 Jul 6.
10
SARS-CoV-2 reinfection.严重急性呼吸综合征冠状病毒2型再次感染
Med Intensiva (Engl Ed). 2021 Aug-Sep;45(6):375-376. doi: 10.1016/j.medine.2021.04.009. Epub 2021 May 2.

引用本文的文献

1
Clinical Characteristics and Outcomes of COVID-Positive Maintenance Hemodialysis Patients: A Study from India.新冠病毒检测呈阳性的维持性血液透析患者的临床特征及预后：一项来自印度的研究。
Indian J Nephrol. 2024 Sep-Oct;34(5):448-452. doi: 10.25259/ijn_288_21. Epub 2024 Jul 15.
2
In-hospital adverse outcomes and risk factors among chronic kidney disease patients infected with the omicron variant of SARS-CoV-2: a single-center retrospective study.奥密克戎变异株感染的慢性肾脏病患者住院不良结局及其危险因素：一项单中心回顾性研究。
BMC Infect Dis. 2023 Oct 18;23(1):698. doi: 10.1186/s12879-023-08620-2.
3
COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review.接受血液透析的老年患者中的 COVID-19：当前综述
Biomedicines. 2023 Mar 16;11(3):926. doi: 10.3390/biomedicines11030926.
4
Which criteria should we use to end isolation in hemodialysis patients with COVID-19?我们应该使用哪些标准来解除新冠肺炎血液透析患者的隔离？
Clin Kidney J. 2022 Apr 30;15(8):1450-1454. doi: 10.1093/ckj/sfac115. eCollection 2022 Aug.
5
Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19.COVID-19 第一波疫情后血液透析患者及其护理人员体内 SARS-COV2 特异性抗体的存在情况。
Sci Rep. 2022 Jul 13;12(1):11972. doi: 10.1038/s41598-022-15913-0.
6
Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.成人接受门诊血液透析的 ESKD 患者中 SARS-CoV-2 感染的临床过程。
Kidney360. 2021 Sep 22;2(12):1917-1927. doi: 10.34067/KID.0004372021. eCollection 2021 Dec 30.
7
Machine Learning for Prediction of Patients on Hemodialysis with an Undetected SARS-CoV-2 Infection.用于预测血液透析患者隐匿性 SARS-CoV-2 感染的机器学习方法。
Kidney360. 2021 Jan 13;2(3):456-468. doi: 10.34067/KID.0003802020. eCollection 2021 Mar 25.
8
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
9
Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis.新冠疫苗在维持性血液透析患者中的有效性
Risk Manag Healthc Policy. 2021 Dec 30;14:5081-5088. doi: 10.2147/RMHP.S345686. eCollection 2021.
10
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients.比较血液透析患者和肾移植受者新冠康复期的体液和细胞适应性免疫
J Clin Med. 2021 Oct 21;10(21):4833. doi: 10.3390/jcm10214833.